Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Live Zoster Vaccine in Healthy Adults
NCT04072497Phase 2Completed
- Sponsor
- Shanghai Institute of Biological Products
- Start
- Nov 2018
- Primary completion
- Apr 2020
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of zoster vaccine live in herpes zoster (HZ), sponsored by Shanghai Institute of Biological Products. Started Nov 2018; status: completed.
02
Drugs
zoster vaccine live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT04072497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04072497.